CPhI 2012 in Madrid

Aesica ramps up HPAPI capacity to meet industry demand

A fear of handling toxic compounds has led to a shortage of HP contracters, according to Aesica

The technical challenge posed by potent APIs means drug industry demand for R&D-scale contract manufacturing is largely unmet, according to Aesica.

Cobra reflects on fill finish acqusition

Cobra Biologics talks recent fill finish acquisition and future growth plans

New import laws spur hopes for reduced trial start-up time in Ukraine

New import laws spur hopes for reduced trial start-up time in Ukraine

Penn Pharma in talks with big players

Penn Pharma in talks with the big boys over new facility

Piramal wants injectables capacity

Piramal looking for injectables capacity but wont overpay

Foreign manufacturers should pick up the extra work created by their regulations, says the Indian Government

Indian pharma regulations should not change to suit others, says the Government

BASF wants a share of pharma omega-3 market

BASF wants a share of pharma omega-3 market

Albemarle sees pharma ‘flight to quality’

Albemarle sees pharma ‘flight to quality’

Novasep invests in French API production

Novasep to invest €30m in large-scale API production plant

The regulators should accept each other's inspections to cover a wider area of the world, says EFCG

Mutual recognition agreements will solve global GMP woes, says EFCG

More CPhI 2012 in Madrid